Cubist Pharma (CBST) Reports Positive Ceftolozane/Tazobactam Phase 3 Topline Results
Tweet Send to a Friend
Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) announced positive top-line results from the Company’s pivotal Phase 3 clinical trial of its antibiotic ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
